Skip to the page

Data / Drug companies / Teva Parenteral Medicines, Inc.

Teva Parenteral Medicines, Inc.: 38 products in the FDA NDC directory, labeler code 0703

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Teva Parenteral Medicines, Inc. (labeler code 0703) lists 38 products in the FDA National Drug Code Directory, covering 10 finished drugs by generic name. By type: 38 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on September 4, 2024.

The request: Watch Teva Parenteral Medicines, Inc. (FDA labeler code 0703): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
0703
Products in commercial distribution
38
Packages
38
Finished drugs by generic name
10
Prescription products
38
Over the counter products
0
Controlled substance products
Schedule II 3
Flagged as original packager
38 of 38 products that carry the flag
Started marketing in the last 12 months
0
Products with a marketing end date set
3
Earliest marketing start
November 1, 1991
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)38100%

Products by type

TypeProductsShare
Prescription drugs38100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Injection, solution2360.5%
Injection, solution, concentrate1334.2%
Injection, suspension25.3%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Metoclopramide0703-4502Injection, solutionGeneric drugs (ANDA)September 4, 2024
Sulfamethoxazole and Trimethoprim0703-9526Injection, solution, concentrateGeneric drugs (ANDA)August 15, 2024
Sulfamethoxazole and Trimethoprim0703-9514Injection, solution, concentrateGeneric drugs (ANDA)July 11, 2024
Paclitaxel0703-3213Injection, solution, concentrateGeneric drugs (ANDA)July 7, 2020
Paclitaxel0703-3213Injection, solution, concentrateGeneric drugs (ANDA)July 7, 2020
Paclitaxel0703-3216Injection, solution, concentrateGeneric drugs (ANDA)March 25, 2020
Paclitaxel0703-3218Injection, solution, concentrateGeneric drugs (ANDA)March 5, 2020
Paclitaxel0703-3218Injection, solution, concentrateGeneric drugs (ANDA)March 5, 2020
Paclitaxel0703-3217Injection, solution, concentrateGeneric drugs (ANDA)March 5, 2020
Paclitaxel0703-3216Injection, solution, concentrateGeneric drugs (ANDA)March 5, 2020
Treprostinil0703-0696Injection, solutionGeneric drugs (ANDA)September 30, 2019
Treprostinil0703-0686Injection, solutionGeneric drugs (ANDA)September 30, 2019
Treprostinil0703-0676Injection, solutionGeneric drugs (ANDA)September 30, 2019
Treprostinil0703-0666Injection, solutionGeneric drugs (ANDA)September 30, 2019
Triamcinolone Acetonide0703-0243Injection, suspensionGeneric drugs (ANDA)August 29, 2019
Triamcinolone Acetonide0703-0241Injection, suspensionGeneric drugs (ANDA)August 29, 2019
Palonosetron Hydrochloride0703-4094Injection, solutionGeneric drugs (ANDA)March 23, 2018
Carboplatin0703-4239Injection, solutionGeneric drugs (ANDA)January 19, 2016
Carboplatin0703-4244Injection, solutionGeneric drugs (ANDA)January 15, 2016
Carboplatin0703-4248Injection, solutionGeneric drugs (ANDA)December 9, 2015
Carboplatin0703-4246Injection, solutionGeneric drugs (ANDA)November 25, 2015
CARBOplatin0703-4239Injection, solutionGeneric drugs (ANDA)October 23, 2014
Methotrexate0703-3678Injection, solutionGeneric drugs (ANDA)August 1, 2012
Methotrexate0703-3675Injection, solutionGeneric drugs (ANDA)August 1, 2012
Methotrexate0703-3671Injection, solutionGeneric drugs (ANDA)July 31, 2012

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.